PCM
Perkins Capital Management Portfolio holdings
AUM
$99.5M
This Quarter Return
+20.63%
1 Year Return
+49.19%
3 Year Return
+174.89%
5 Year Return
+322.89%
10 Year Return
–
AUM
$100M
AUM Growth
+$100M
(+15%)
Cap. Flow
+$5.92M
Cap. Flow
% of AUM
5.92%
Top 10 Holdings %
Top 10 Hldgs %
33.7%
Holding
128
New
12
Increased
27
Reduced
32
Closed
16
Top Buys
| 1 |
Tactile Systems Technology
TCMD
|
$1.81M |
| 2 |
Apyx Medical
APYX
|
$1.52M |
| 3 |
Surmodics
SRDX
|
$1.32M |
| 4 |
AVP
Avon Products, Inc.
AVP
|
$1.27M |
| 5 |
Assertio
ASRT
|
$1.15M |
Top Sells
| 1 |
BEAT
BioTelemetry, Inc.
BEAT
|
$1.96M |
| 2 |
ePlus
PLUS
|
$1.61M |
| 3 |
Boston Scientific
BSX
|
$1.18M |
| 4 |
OUTR
OUTERWALL INC
OUTR
|
$853K |
| 5 |
LeMaitre Vascular
LMAT
|
$545K |
Sector Composition
| 1 | Healthcare | 60.78% |
| 2 | Technology | 11.61% |
| 3 | Industrials | 8.59% |
| 4 | Consumer Staples | 4.07% |
| 5 | Communication Services | 3.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Axogen
AXGN
$743M
| $5.61M | 5.61% | 620,908 -11,000 | -2% | -$99.3K |
|
2
NeoGenomics
NEO
$1.13B
| $5.39M | 5.39% | 655,800 -17,232 | -3% | -$142K |
|
|
STJ
3
DELISTED
St Jude Medical
STJ
| $5.32M | 5.32% | 66,673 | – | – |
|
|
4
Apyx Medical
APYX
$75.3M
| $3.37M | 3.37% | 647,035 +291,295 | +82% | +$1.52M |
|
5
Rockwell Medical
RMTI
$58.9M
| $2.97M | 2.97% | 443,350 -35,300 | -7% | -$236K |
|
|
CSII
6
DELISTED
Cardiovascular Systems, Inc.
CSII
| $2.65M | 2.65% | 111,600 | – | – |
|
7
Altimmune
ALT
$338M
| $2.38M | 2.38% | 820,000 -44,000 | -5% | -$128K |
|
|
8
LeMaitre Vascular
LMAT
$2.16B
| $2.2M | 2.2% | 110,883 -27,475 | -20% | -$545K |
|
9
AtriCure
ATRC
$1.84B
| $1.93M | 1.92% | 121,700 +36,600 | +43% | +$579K |
|
|
10
Assertio
ASRT
$80.4M
| $1.9M | 1.9% | 76,100 +46,100 | +154% | +$1.15M |
|
|
SNAK
11
DELISTED
Inventure Foods, Inc.
SNAK
| $1.87M | 1.87% | 198,750 -1,000 | -0.5% | -$9.4K |
|
12
Pfizer
PFE
$141B
| $1.85M | 1.85% | 54,629 -1,000 | -2% | -$33.9K |
|
|
13
Tactile Systems Technology
TCMD
$297M
| $1.81M | 1.81% | +96,961 | New | +$1.81M |
|
|
CGNT
14
DELISTED
Cogentix Medical, Inc.
CGNT
| $1.78M | 1.78% | 979,610 -36,461 | -4% | -$66.4K |
|
15
Eli Lilly
LLY
$657B
| $1.58M | 1.58% | 19,700 | – | – |
|
16
Idexx Laboratories
IDXX
$51.8B
| $1.58M | 1.58% | 14,000 | – | – |
|
|
VYNT
17
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
| $1.51M | 1.51% | 864,600 +283,400 | +49% | +$496K |
|
18
Cantaloupe
CTLP
$797M
| $1.35M | 1.35% | 240,400 +2,000 | +0.8% | +$11.2K |
|
|
19
Surmodics
SRDX
$487M
| $1.32M | 1.32% | +43,750 | New | +$1.32M |
|
20
Microsoft
MSFT
$3.77T
| $1.29M | 1.29% | 22,460 +3,725 | +20% | +$215K |
|
|
SVU
21
DELISTED
SUPERVALU Inc.
SVU
| $1.29M | 1.29% | 258,150 -2,000 | -0.8% | -$9.98K |
|
|
AVP
22
DELISTED
Avon Products, Inc.
AVP
| $1.27M | 1.27% | +224,500 | New | +$1.27M |
|
|
ZIXI
23
DELISTED
Zix Corporation
ZIXI
| $1.24M | 1.24% | 301,549 -1,990 | -0.7% | -$8.16K |
|
|
TEAR
24
DELISTED
TearLab Corporation
TEAR
| $1.2M | 1.2% | 1,848,242 +93,000 | +5% | +$60.4K |
|
25
Abbott
ABT
$231B
| $1.19M | 1.19% | 28,175 +2,100 | +8% | +$88.8K |
|